AstraZeneca's Fasenra did not meet the primary endpoint in chronic obstructive pulmonary disease patients compared with placebo.
This Site is Intended for Healthcare Professionals Only
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Start your day right!
Get the latest updates and insights delivered to your inbox
Science minister Patrick Vallance says that appropriate access and payment for medicines was a "crunch issue".
Getty Images
Cataracts topped the list with 374,072 hospital admissions, a 17 percent increase from the previous year.
iStock
A NPA survey found that many patients have to wait if a medicine is out of stock and pharmacists cannot provide alternatives because of Medicines Act 1968.
Pic credit
×
Terms and Conditions
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Asian Trade
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at
data@amg.biz
to see how we manage and store your data.
×
Terms and Conditions
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Asian Trade
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.